ZD1839 (‘Iressa’) improves the antitumour activity of tamoxifen (‘Nolvadex’) and ICI 182, 780 (‘Faslodex’) in antihormone responsive breast cancer
- 30 November 2002
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 38, S59
- https://doi.org/10.1016/s0959-8049(02)80835-8